These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1146925)

  • 1. Prostaglandins in the human endometrium. Gas chromatographic-mass spectrometric quantitation before and after IUD insertion.
    Green K; Hagenfeldt K
    Am J Obstet Gynecol; 1975 Jul; 122(5):611-4. PubMed ID: 1146925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous levels of prostaglandin F2alpha and its main metabolites in plasma and endometrium of normal and dysmenorrheic women.
    Lundström V; Gréen K
    Am J Obstet Gynecol; 1978 Mar; 130(6):640-6. PubMed ID: 637076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of concentration of endometrial prostaglandin in early intra-uterine and ectopic pregnancy in women.
    Abel MH; Smith SK; Baird DT
    J Endocrinol; 1980 Jun; 85(3):379-86. PubMed ID: 7411005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone and estradiol patterns in women using an intrauterine contraceptive device.
    Brenner PF; Mishell DR
    Obstet Gynecol; 1975 Oct; 46(4):456-9. PubMed ID: 1165881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms behind intrauterine device-induced luteal persistence in mares.
    Rivera Del Alamo MM; Reilas T; Kindahl H; Katila T
    Anim Reprod Sci; 2008 Aug; 107(1-2):94-106. PubMed ID: 17643876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassays for prostaglandin metabolites.
    Granström E; Kindahl H
    Adv Prostaglandin Thromboxane Res; 1976; 1():81-92. PubMed ID: 63236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intrauterine progesterone treatment on the endometrial prostaglandin F content in the rabbit.
    Scommegna A; Ilekis J; Sotrel G; Auletta FJ
    Fertil Steril; 1977 May; 28(5):581-6. PubMed ID: 856639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible role of prostaglandin E1 in the mechanism of action of intrauterine contraceptive device.
    Das R; Hrishikeshwan HJ; Bapna JS; Dandiya PC; Ramesh S
    Indian J Med Res; 1977 Mar; 65(3):353-6. PubMed ID: 924547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine devices influence prostaglandin secretion by equine uterus: in vitro and in vivo studies.
    Piotrowska-Tomala KK; Jonczyk AW; Szóstek-Mioduchowska A; Hojo T; Żebrowska E; Katila T; Ferreira-Dias G; Skarzynski DJ
    BMC Vet Res; 2024 Feb; 20(1):46. PubMed ID: 38310284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E and F concentrations in human endometrium after insertion of intrauterine contraceptive device.
    Hillier K; Kasonde JM
    Lancet; 1976 Jan; 1(7949):15-6. PubMed ID: 54517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ The radioimmunoassay of prostaglandins F in human plasma and endometrium (author's transl)].
    Tresguerres JA; Oriol Bosch A
    Reproduccion; 1974; 1(3):289-97. PubMed ID: 4464173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostaglandins and intrauterine contraceptive device].
    Zhu JH
    Shengzhi Yu Biyun; 1987; 7(1):3-5. PubMed ID: 12341307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of intrauterine contraceptive device on expression of vascular endothelial growth factor, kinase insert domain-containing receptor and microvessel density in endometrium].
    Xin ZM; Xie QZ; Cao LM; Sun YP; Su YC; Guo YH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):771-5. PubMed ID: 15634506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the levels of precursors of endogenous synthesis of prostaglandins in intrauterine contraception].
    Klimets II; Kravchenko EV
    Akush Ginekol (Mosk); 1989 Oct; (10):63-4. PubMed ID: 2618960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological study of the endometrium of 459 intrauterine contraceptive device (IUD) users.
    Katsura S; Satodade R
    Yokohama Med Bull; 1969 Oct; 20(5):137-44. PubMed ID: 5402647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin content of human endometrium.
    Levitt MJ; Tobon H; Josimovich JB
    Fertil Steril; 1975 Mar; 26(3):296-300. PubMed ID: 1116624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the cancer risk of intrauterine contraception based on cytological studies of the endometrium].
    Petrov IuA
    Vopr Onkol; 1985; 31(12):53-6. PubMed ID: 4082508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the copper-T 200 IUD on the luteal phase plasma progesterone concentration in the normal menstrual cycle.
    Haukkamaa M; Luukkainen T; Timonen H
    Ann Clin Res; 1974 Feb; 6(1):40-4. PubMed ID: 4820609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.